Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sulfasalazine hepatotoxicity.

A Fich, J Schwartz, D Braverman

    The American Journal of Gastroenterology
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis.

    PloS one·2017
    Same author

    Associations Between Crohn's Disease Severity And Specific Socio-Demographic, Quality-Of-Life And Coping Factors.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trial.

    The American journal of gastroenterology·2015
    Same author

    Inflammatory bowel disease: the asthma of the intestine?

    Inflammatory bowel diseases·2013
    Same author

    The association between smoking and inflammatory bowel disease among israeli jewish patients.

    Inflammatory bowel diseases·2013
    Same author

    The clinical course of pulmonary tuberculosis.

    Harefuah·2010
    Same journal

    Calendar of Courses, Symposiums and Conferences.

    The American journal of gastroenterology·2026
    Same journal

    Molecular Nonendoscopic Tests for the Early Detection of Esophageal Squamous Carcinoma and High-Grade Dysplasia: Promising Progress.

    The American journal of gastroenterology·2026
    Same journal

    ACG Clinical Guideline: Colonic Diverticulitis.

    The American journal of gastroenterology·2026
    Same journal

    Continuing Medical Education Questions: July 2026.

    The American journal of gastroenterology·2026
    Same journal

    Continuing Medical Education Questions: July 2026.

    The American journal of gastroenterology·2026
    Same journal

    2026 CME Information.

    The American journal of gastroenterology·2026
    See all related articles

    Sulfasalazine can rarely cause liver damage (hepatotoxicity). In one case, liver biopsy showed granulomatous hepatitis, while another patient had a hypersensitivity reaction to 5-aminosalicylic acid.

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Pharmacology

    Background:

    • Sulfasalazine is a medication used to treat inflammatory bowel disease and rheumatoid arthritis.
    • Hepatotoxicity is a known, albeit rare, adverse effect of sulfasalazine therapy.

    Observation:

    • This report details two cases of patients experiencing adverse events following sulfasalazine treatment.
    • One patient presented with significant hepatic damage attributed to sulfasalazine.

    Findings:

    • Liver biopsy in the affected patient revealed granulomatous hepatitis, a specific inflammatory liver condition.
    • The second patient, upon rechallenge with 5-aminosalicylic acid enema, exhibited a hypersensitivity reaction but without liver involvement.

    Implications:

    Related Experiment Videos

    • These cases highlight the importance of monitoring for liver injury in patients on sulfasalazine.
    • Understanding the distinct reactions to sulfasalazine and its metabolite is crucial for patient management.
    • Further investigation into the mechanisms of sulfasalazine-induced hepatotoxicity is warranted.